June 15 (Reuters) - Avalon Rare Metals Inc AVL.TO :
* Ventures says launch of three new companies formed through its ongoing
collaboration with GSK
* Ventures-cadherx therapeutics,calporta therapeutics,to each get up to $10
million in series a financing,r&d support from Avalon ventures and gsk
* Ventures-to provide adrenergics,cadherx,calporta with operational management
consistent with its current portfolio strategy
* Ventures-gsk has the option to acquire each of the companies upon the
identification of a clinical candidate
* Ventures-should gsk elect not to exercise acquisition option on any of the
companies, ownership of those companies will remain with Avalon
* Source text for Eikon ID:nPn6ZpXCv
* Further company coverage AVL.TO ((Bengaluru Newsroom; +1 646 223 8780))